Randomised phase III trial of radical chemo/radiotherapy vs radiotherapy alone in the definitive management of localised muscle invasive TCC of the urinary bladder
Primary Sponsor
Urological Society of Australasia
Collaborating Groups
Trans Tasman Radiation Oncology Group (TROG)
Final Accrual
67
Trial Chairperson
Dr Kumar Gogna, QRI Mater Centre, QLD
Trial Contact
Kumar Gogna
Clinical Trial Registration
Related Post
26 November, 2025
TROG Member Prof Paul Keall’s innovative research recognised in two Premier’s Awards
LATEST NEWS; 26 November 2025 Medical physics researcher and
25 November, 2025
Automated quality assurance tool shows promise in TROG 18.01 NINJA trial
LATEST NEWS: 25 November 2025 Vital quality assurance (QA)